Review



e2 e2 640 r d systems  (R&D Systems)


Bioz Verified Symbol R&D Systems is a verified supplier
Bioz Manufacturer Symbol R&D Systems manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 93

    Structured Review

    R&D Systems e2 e2 640 r d systems
    E2 E2 640 R D Systems, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 16 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/e2 e2 640 r d systems/product/R&D Systems
    Average 93 stars, based on 16 article reviews
    e2 e2 640 r d systems - by Bioz Stars, 2026-05
    93/100 stars

    Images



    Similar Products

    93
    MedChemExpress ubiquitin conjugating enzyme
    Ubiquitin Conjugating Enzyme, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/ubiquitin conjugating enzyme/product/MedChemExpress
    Average 93 stars, based on 1 article reviews
    ubiquitin conjugating enzyme - by Bioz Stars, 2026-05
    93/100 stars
      Buy from Supplier

    93
    R&D Systems e2 e2 640 r d systems
    E2 E2 640 R D Systems, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/e2 e2 640 r d systems/product/R&D Systems
    Average 93 stars, based on 1 article reviews
    e2 e2 640 r d systems - by Bioz Stars, 2026-05
    93/100 stars
      Buy from Supplier

    93
    R&D Systems ube2l3
    A Schematic representation of the UBA1 gene, highlighting its functional domains and pinpointing the exact locations of the identified UBA1 variants. The variants were classified into Tier-1 (pathogenic: P), Tier-2 (likely pathogenic: LP) and Tier-3 (variant of uncertain significance: VUS), as depicted in the outer pie chart on the left. UBA1 variants are displayed on top of the gene if the locus occurred recurrently in our screen. Combination of variants detected in the same patients are also shown. Variants detected only as combinations are italicized. M41 and other tier assignments are color-coded. Bold underlined variants were tested for functional significance. B Chart summarizing UBA1 variants and their functional status, indicating the presence or absence of ubiquitylation. Quantification of polyubiquitin levels and mono-ubiquitylated histone H2A/B (Ub-H2A, Ub-H2B) or E2 enzymes (UBE2D3-Ub, <t>UBE2L3-Ub)</t> were normalized within each sample to β-actin levels and scaled to WT transfection. E2 enzyme ubiquitylation was quantified as the ratio of charged form to uncharged form and scaled to WT. Data represent n = 3–6 biological replicates, shown as mean −/+ s.d., significance determined by unpaired t-test with Welch’s correction (*p < 0.05, **p < 0.01).
    Ube2l3, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/ube2l3/product/R&D Systems
    Average 93 stars, based on 1 article reviews
    ube2l3 - by Bioz Stars, 2026-05
    93/100 stars
      Buy from Supplier

    95
    R&D Systems e2 r d systems ubch5c cat e2 627 ubch7 cat e2 640 ubch8 cat e2 643
    A Schematic representation of the UBA1 gene, highlighting its functional domains and pinpointing the exact locations of the identified UBA1 variants. The variants were classified into Tier-1 (pathogenic: P), Tier-2 (likely pathogenic: LP) and Tier-3 (variant of uncertain significance: VUS), as depicted in the outer pie chart on the left. UBA1 variants are displayed on top of the gene if the locus occurred recurrently in our screen. Combination of variants detected in the same patients are also shown. Variants detected only as combinations are italicized. M41 and other tier assignments are color-coded. Bold underlined variants were tested for functional significance. B Chart summarizing UBA1 variants and their functional status, indicating the presence or absence of ubiquitylation. Quantification of polyubiquitin levels and mono-ubiquitylated histone H2A/B (Ub-H2A, Ub-H2B) or E2 enzymes (UBE2D3-Ub, <t>UBE2L3-Ub)</t> were normalized within each sample to β-actin levels and scaled to WT transfection. E2 enzyme ubiquitylation was quantified as the ratio of charged form to uncharged form and scaled to WT. Data represent n = 3–6 biological replicates, shown as mean −/+ s.d., significance determined by unpaired t-test with Welch’s correction (*p < 0.05, **p < 0.01).
    E2 R D Systems Ubch5c Cat E2 627 Ubch7 Cat E2 640 Ubch8 Cat E2 643, supplied by R&D Systems, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/e2 r d systems ubch5c cat e2 627 ubch7 cat e2 640 ubch8 cat e2 643/product/R&D Systems
    Average 95 stars, based on 1 article reviews
    e2 r d systems ubch5c cat e2 627 ubch7 cat e2 640 ubch8 cat e2 643 - by Bioz Stars, 2026-05
    95/100 stars
      Buy from Supplier

    93
    R&D Systems ube2l3 ubch7
    A Schematic representation of the UBA1 gene, highlighting its functional domains and pinpointing the exact locations of the identified UBA1 variants. The variants were classified into Tier-1 (pathogenic: P), Tier-2 (likely pathogenic: LP) and Tier-3 (variant of uncertain significance: VUS), as depicted in the outer pie chart on the left. UBA1 variants are displayed on top of the gene if the locus occurred recurrently in our screen. Combination of variants detected in the same patients are also shown. Variants detected only as combinations are italicized. M41 and other tier assignments are color-coded. Bold underlined variants were tested for functional significance. B Chart summarizing UBA1 variants and their functional status, indicating the presence or absence of ubiquitylation. Quantification of polyubiquitin levels and mono-ubiquitylated histone H2A/B (Ub-H2A, Ub-H2B) or E2 enzymes (UBE2D3-Ub, <t>UBE2L3-Ub)</t> were normalized within each sample to β-actin levels and scaled to WT transfection. E2 enzyme ubiquitylation was quantified as the ratio of charged form to uncharged form and scaled to WT. Data represent n = 3–6 biological replicates, shown as mean −/+ s.d., significance determined by unpaired t-test with Welch’s correction (*p < 0.05, **p < 0.01).
    Ube2l3 Ubch7, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/ube2l3 ubch7/product/R&D Systems
    Average 93 stars, based on 1 article reviews
    ube2l3 ubch7 - by Bioz Stars, 2026-05
    93/100 stars
      Buy from Supplier

    93
    Boston Biochem ubiquitin e2 enzyme ubch7

    Ubiquitin E2 Enzyme Ubch7, supplied by Boston Biochem, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/ubiquitin e2 enzyme ubch7/product/Boston Biochem
    Average 93 stars, based on 1 article reviews
    ubiquitin e2 enzyme ubch7 - by Bioz Stars, 2026-05
    93/100 stars
      Buy from Supplier

    93
    R&D Systems ubch7
    Figure 1. In vitro reconstitution of STAM1 ubiquitination by AIP4. A, STAM1 ubiquitination by AIP4 was reconstituted in vitro and performed in the presence of increasing concentrations of βarrestin1. Ubiquitination reactions comprised of E1(Ube1, 42 nM), E2 <t>(UbcH7,</t> 350 nM), E3 (AIP4, 48.5 nM), ubiquitin (11.6 μM), DTT (1 mM), ATP (1 mM) plus STAM1 (42 nM), and varying concentrations of βarr1 (0 nM, 20 nM, 40 nM, 80 nM, 160 nM, or 320 nM) in 40 μl. Reactions were incubated for 90 min at 37 C and terminated with 40 μl 2× sample buffer. Equal volumes were analyzed by 7% SDS-PAGE and immunoblotting with the indicated antibodies. Polyubiquitinated [Ub(n)] and unmodified STAM1 are indicated. Immunoblots are from one representative experiment. STAM1 ubiquitination was quantified from the STAM (B) and ubiquitin (C) immunoblots using densitometry and shown as line graphs. Data were expressed relative to the signal at 300 nM βarr1 and represent the mean ± S.D. from three independent experiments. Curves were fitted by nonlinear regression, Michaelis–Menten (GraphPad Prism). AIP4, atrophin-interacting protein 4; STAM, signal-transducing adaptor molecule.
    Ubch7, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/ubch7/product/R&D Systems
    Average 93 stars, based on 1 article reviews
    ubch7 - by Bioz Stars, 2026-05
    93/100 stars
      Buy from Supplier

    Image Search Results


    A Schematic representation of the UBA1 gene, highlighting its functional domains and pinpointing the exact locations of the identified UBA1 variants. The variants were classified into Tier-1 (pathogenic: P), Tier-2 (likely pathogenic: LP) and Tier-3 (variant of uncertain significance: VUS), as depicted in the outer pie chart on the left. UBA1 variants are displayed on top of the gene if the locus occurred recurrently in our screen. Combination of variants detected in the same patients are also shown. Variants detected only as combinations are italicized. M41 and other tier assignments are color-coded. Bold underlined variants were tested for functional significance. B Chart summarizing UBA1 variants and their functional status, indicating the presence or absence of ubiquitylation. Quantification of polyubiquitin levels and mono-ubiquitylated histone H2A/B (Ub-H2A, Ub-H2B) or E2 enzymes (UBE2D3-Ub, UBE2L3-Ub) were normalized within each sample to β-actin levels and scaled to WT transfection. E2 enzyme ubiquitylation was quantified as the ratio of charged form to uncharged form and scaled to WT. Data represent n = 3–6 biological replicates, shown as mean −/+ s.d., significance determined by unpaired t-test with Welch’s correction (*p < 0.05, **p < 0.01).

    Journal: Leukemia

    Article Title: Distinct characteristics of VEXAS-causative UBA1 M41 and recurrent functional non-M41 mutations

    doi: 10.1038/s41375-025-02775-4

    Figure Lengend Snippet: A Schematic representation of the UBA1 gene, highlighting its functional domains and pinpointing the exact locations of the identified UBA1 variants. The variants were classified into Tier-1 (pathogenic: P), Tier-2 (likely pathogenic: LP) and Tier-3 (variant of uncertain significance: VUS), as depicted in the outer pie chart on the left. UBA1 variants are displayed on top of the gene if the locus occurred recurrently in our screen. Combination of variants detected in the same patients are also shown. Variants detected only as combinations are italicized. M41 and other tier assignments are color-coded. Bold underlined variants were tested for functional significance. B Chart summarizing UBA1 variants and their functional status, indicating the presence or absence of ubiquitylation. Quantification of polyubiquitin levels and mono-ubiquitylated histone H2A/B (Ub-H2A, Ub-H2B) or E2 enzymes (UBE2D3-Ub, UBE2L3-Ub) were normalized within each sample to β-actin levels and scaled to WT transfection. E2 enzyme ubiquitylation was quantified as the ratio of charged form to uncharged form and scaled to WT. Data represent n = 3–6 biological replicates, shown as mean −/+ s.d., significance determined by unpaired t-test with Welch’s correction (*p < 0.05, **p < 0.01).

    Article Snippet: Primary antibodies for Poly-ubiquitin (Cell Signaling, 3936S), UBE2D3 (Cell-Signaling, 4330), UBE2L3 (R&D Systems, E2-640), ubiquitylated-H2A (Cell Signaling, 8240), H2A (Cell Signaling, 12349), ubiquitylated-H2B (Cell Signaling, 5546S), H2B (Cell Signaling, 12364), and β-actin (Cell Signaling, 4970) were used at a concentration of 1:1000 and visualized using HRP-conjugated secondary antibodies (anti-rabbit [Cell Signaling, 7074S] or anti-mouse [Cell Signaling, 7076S]) at a concentration of 1:3000.

    Techniques: Functional Assay, Variant Assay, Transfection

    Journal: iScience

    Article Title: Trichinella spiralis inhibits myoblast differentiation by targeting SQSTM1/p62 with a secreted E3 ubiquitin ligase

    doi: 10.1016/j.isci.2024.109102

    Figure Lengend Snippet:

    Article Snippet: Ubiquitin E2 Enzyme UbcH7 , Boston Biochem, USA , Cat#E2-640.

    Techniques: Recombinant, Ubiquitin Proteomics, Conjugation Assay, Transfection, Plasmid Preparation, Software

    Figure 1. In vitro reconstitution of STAM1 ubiquitination by AIP4. A, STAM1 ubiquitination by AIP4 was reconstituted in vitro and performed in the presence of increasing concentrations of βarrestin1. Ubiquitination reactions comprised of E1(Ube1, 42 nM), E2 (UbcH7, 350 nM), E3 (AIP4, 48.5 nM), ubiquitin (11.6 μM), DTT (1 mM), ATP (1 mM) plus STAM1 (42 nM), and varying concentrations of βarr1 (0 nM, 20 nM, 40 nM, 80 nM, 160 nM, or 320 nM) in 40 μl. Reactions were incubated for 90 min at 37 C and terminated with 40 μl 2× sample buffer. Equal volumes were analyzed by 7% SDS-PAGE and immunoblotting with the indicated antibodies. Polyubiquitinated [Ub(n)] and unmodified STAM1 are indicated. Immunoblots are from one representative experiment. STAM1 ubiquitination was quantified from the STAM (B) and ubiquitin (C) immunoblots using densitometry and shown as line graphs. Data were expressed relative to the signal at 300 nM βarr1 and represent the mean ± S.D. from three independent experiments. Curves were fitted by nonlinear regression, Michaelis–Menten (GraphPad Prism). AIP4, atrophin-interacting protein 4; STAM, signal-transducing adaptor molecule.

    Journal: The Journal of biological chemistry

    Article Title: β-arrestin1 is an E3 ubiquitin ligase adaptor for substrate linear polyubiquitination.

    doi: 10.1016/j.jbc.2023.105474

    Figure Lengend Snippet: Figure 1. In vitro reconstitution of STAM1 ubiquitination by AIP4. A, STAM1 ubiquitination by AIP4 was reconstituted in vitro and performed in the presence of increasing concentrations of βarrestin1. Ubiquitination reactions comprised of E1(Ube1, 42 nM), E2 (UbcH7, 350 nM), E3 (AIP4, 48.5 nM), ubiquitin (11.6 μM), DTT (1 mM), ATP (1 mM) plus STAM1 (42 nM), and varying concentrations of βarr1 (0 nM, 20 nM, 40 nM, 80 nM, 160 nM, or 320 nM) in 40 μl. Reactions were incubated for 90 min at 37 C and terminated with 40 μl 2× sample buffer. Equal volumes were analyzed by 7% SDS-PAGE and immunoblotting with the indicated antibodies. Polyubiquitinated [Ub(n)] and unmodified STAM1 are indicated. Immunoblots are from one representative experiment. STAM1 ubiquitination was quantified from the STAM (B) and ubiquitin (C) immunoblots using densitometry and shown as line graphs. Data were expressed relative to the signal at 300 nM βarr1 and represent the mean ± S.D. from three independent experiments. Curves were fitted by nonlinear regression, Michaelis–Menten (GraphPad Prism). AIP4, atrophin-interacting protein 4; STAM, signal-transducing adaptor molecule.

    Article Snippet: UbcH7 (E2; cat# E2-640–100), lysine-less ubiquitin (0K-Ub; cat# UM-NOK) and lysine-less biotinylated ubiquitin (0K-Ub biotin; cat# UB-560) were from R&D Systems.

    Techniques: In Vitro, Ubiquitin Proteomics, Incubation, SDS Page, Western Blot